Interleukins 4 and 6 as factors of modulation of subpopulation composition of blood monocytes in patients with ischemic cardiomyopathy

Abstract

Aim. To evaluate the ratio of the fractions of classical, intermediate, non-classical and transitional monocytes in correlation with the concentration of interleukins 4 and 6 in the blood of patients with ischemic cardiomyopathy.

Methods. 18 patients with ischemic cardiomyopathy (17 men and 1 woman) aged 47-66 years with circulatory insufficiency of functional class II-III according to the classification of heart failure of the New York Heart Association, were examined. The control group included 14 healthy donors matched by gender and age to patients with ischemic cardiomyopathy without any diseases of cardiovascular system and other systems in an exacerbation stage. In blood of the patients with ischemic cardiomyopathy, the relative content of classical (CD14++CD16-), intermediate (CD14++CD16+), non-classical (CD14+CD16+) and transitional (CD14+CD16-) monocytes was assessed by flow cytometry and the concentration of interleukins 4 and 6 by enzyme-linked immunosorbent assay (ELISA).

Results. It was shown that the number of non-classical monocytes in the blood of patients with ischemic cardiomyopathy was 2 times lower than normal (5.05 % [4.08; 6.58] and 10.07 % [9.34; 13.84], respectively, p < 0.01), as well as the concentration of interleukin-4 (0.02 pg/ml [0; 0.04] and 0.15 pg/ml [0.05; 0.65], respectively, p < 0.05). The number of classical monocytes in the blood of patients had a tendency to decrease, and the proportion of intermediate monocytes and the concentration of interleukin-6, on the contrary, were slightly higher than in healthy individuals, and were interdependent (r = 0.61; p < 0.05). The relative content of transitional monocytes in the blood was comparable with that of healthy donors.

Conclusions. The subpopulation composition of blood monocytes in patients with ischemic cardiomyopathy is characterized by a deficiency of the fraction of non-classical monocytes with protective properties against endothelium, and interleukin-4 in the blood with a certain increase in the content of interleukin-6 and the number of intermediate cells with ability to cooperate with T-lymphocytes, which predisposes to diffuse atheromatosis of small coronary arteries and diffuse hypoxic myocardial damage in ischemic cardiomyopathy.

Keywords

monocytes / subpopulation composition of monocytes / cytokines / interleukins / ischemic cardiomyopathy

References

[1] Richardson P., McKenna W., Bristow M., et al. Report of the 1995 World Health Organization / ­International Society and Federation of Cardiology Task Force on the Definitionand Classification of cardiomyopathies. Circulation. 1996; 93 (5): 841–842. DOI: 10.1161/01.CIR.93.5.841.

[2] Richardson P., McKenna W., Bristow M., et al. Report of the 1995 World Health Organization / International Society and Federation of Cardiology Task Force on the Definitionand Classification of cardiomyopathies. Circulation. 1996; 93 (5): 841-842. DOI: 10.1161/01.CIR.93.5.841.

[3] Osovskaya N.Y. Ischemic cardiomyopathy: terminology, epidemiology, pathophysio­logy, diagnosis, therapeutic approach. Novosti meditsiny i farmacii. 2011; 359: 16–19. (In Russ.)

[4] Осовская Н.Ю. Ишемическая кардиомиопатия: терминология, эпидемиология, патофизиология, диагностика, подходы к лечению. Новости медицины и фармации. 2011; 359: 16-19.

[5] Bartekova M., Radosinska J., Jelemensky M., Dhalla N.S. Role of cytokines and inflammation in heart function during health and disease. Heart Fail. Rev. 2018; 23 (5): 733–758. DOI: 10.1007/s10741-018-9716-x.

[6] Bartekova M., Radosinska J., Jelemensky M., Dhalla N.S. Role of cytokines and inflammation in heart function during health and disease. Heart Fail. Rev. 2018; 23 (5): 733-758. DOI: 10.1007/s10741-018-9716-x.

[7] Lezhnjov A.A., Shipulin V.M., Krivoshhekov E.V. Postoperative left ventricular remodeling. Clinical and morphological aspects. LAP Lambert Academic Publishing. 2012; 152 р. (In Russ.)

[8] Лежнёв А.А., Шипулин В.М., Кривощеков Е.В. Послеоперационное ремоделирование левого желудочка. Клинические и морфологические аспекты. LAP Lambert Academic Publishing. 2012; 152 с.

[9] Guddeti R.R., Matsuo Y., Matsuzawa Y., Kushwaha S.S., Lerman A. Ischemic cardiomyopathy is associated with coronary plaque progression and higher event rate in patients after cardiac transplantation. J. Am. Heart. Assoc. 2014; 3 (4): 10–91. DOI: 10.1161/JAHA.114.001091.

[10] Guddeti R.R., Matsuo Y., Matsuzawa Y., Kushwaha S.S., Lerman A. Ischemic cardiomyopathy is associated with coronary plaque progression and higher event rate in patients after cardiac transplantation. J. Am. Heart. Assoc. 2014; 3 (4): 10-91. DOI: 10.1161/JAHA.114.001091.

[11] Kovalenko V.N., Gavrish A.S. Ischemic cardiomyopathy: neurohumoral and immuno-inflammatory aspects of pato- and ­morphogenesis. Ukrainskii kardiologicheskii zhurnal. 2013; 4: ­14–20. (In Russ.)

[12] Коваленко В.Н., Гавриш А.С. Ишемическая кардиомиопатия: нейрогуморальные иммуновоспалительные аспекты пато- и морфогенеза. Украинский кардиологический журнал. 2013; 4: 14-20.

[13] Ziegler-Heitbrock L. The CD14+CD16+ blood monocytes: their role infection and inflammation. J. Leukoc. Biol. 2007; 3: 584–592. DOI: 10.1189/jlb.0806510.

[14] Ziegler-Heitbrock L. The CD14+CD16+ blood monocytes: their role infection and inflammation. J. Leukoc. Biol. 2007; 3: 584-592. DOI: 10.1189/jlb.0806510.

[15] Ziegler-Heitbrock L., Hofer T.P.J. Toward a refined definition of monocyte subsets. Front. Immunol. 2013; 4: 23. DOI:10.3389/fimmu.2013.00023.

[16] Matveeva V.G., Golovkin A.S., Kudryavtsev I.V., Grigoriev E.V., Chernova M.N. Dynamics of CD14+CD16+ monocytes subpopulations in complication-free systemic inflammatory response following coronary artery bypass graft surgery. Meditsinskaya immunologia. 2012; 14 (4–5): 391–398. (In Russ.)

[17] Матвеева В.Г., Головкин А.С., Кудрявцев И.В., Григорьев Е.В., Чернова М.Н. Динамика CD14+CD16+ субпопуляций моноцитов при неосложненном системном воспалительном ответе в периоперационном периоде коронарного шунтирования. Медицинская иммунология. 2012; 14 (4-5): 391-398.

[18] Kazakov V.A., Shipulin V.M., Lezhnev A.A., Kozlov B.N., Krivoshhekov E.V., Suhodolo I.V., Gutor S.S. The clinic and morphological parallels postoperative remodeling of the left ventricle. Patologiya krovoobrasheniya i ­kardiohirurgia. 2009; 4: 23–27. (In Russ.)

[19] Казаков В.А., Шипулин В.М., Лежнев А.А., Козлов Б.Н., Кривощеков Е.В., Суходоло И.В., Гутор С.С. Клинико-морфологические параллели послеоперационного ремоделирования левого желудочка. Патология кровообращения и кардиохирургия. 2009; 4: 23-27.

[20] Kazakov V.A., Suhodolo V.I., Shipulin V.M. Ultrastructural aspects of postinfarction remodeling of the left ventricle. Sibirskii meditsinskiy ­zhurnal. 2009; 4: 6–11. (In Russ.)

[21] Казаков В.А., Суходоло В.И., Шипулин В.М. Ультраструктурные аспекты постинфарктного ремоделирования левого желудочка. Сибирский медицинский журнал. 2009; 4: 6-11.

[22] Italiani P., Boraschi D. From Monocytes to M1/M2 Macrophages: Phenotypical vs. Functional Differentiation. Front. Immunol. 2014; 5: 514. DOI: 10.3389/

[23] Italiani P., Boraschi D. From Monocytes to M1/M2 Macrophages: Phenotypical vs. Functional Differentiation. Front. Immunol. 2014; 5: 514. DOI: 10.3389/fimmu.2014.00514.

[24] fimmu.2014.00514.

[25] Dutta P., Nahrendorf M. Monocytes in myocardial infarction. Arterioscler., Thromb., Vasc. Biol. 2015; 35: 1066-1070. DOI: 10.1161/ATVBAHA.114.304652.

[26] Dutta P., Nahrendorf M. Monocytes in ­myocardial infarction. Arterioscler., Thromb., Vasc. Biol. 2015; 35: 1066–1070. DOI: 10.1161/ATVBAHA.114.304652.

[27] Barisionea C., Garibaldia S., Ghigliottia G., Fabbia P., Altieria P., Casalea M., Spallarossaa P., Berteroa G., Balbia M., Corsigliab L., Brunellia C. CD14CD16 monocyte subset levels in heart failure patients. Disease Marker. 2010; 28 (2): 115-124. DOI: 10.3233/DMA-2010-0691.

[28] Barisionea C., Garibaldia S., Ghigliottia G., Fabbia P., Altieria P., Casalea M., Spallarossaa P., Berteroa G., Balbia M., Corsigliab L., Brunellia C. CD14CD16 monocyte subset levels in heart failure patients. Disease Marker. 2010; 28 (2): 115–124. DOI: 10.3233/DMA-2010-0691.

[29] Лилли Л.С. Патофизиология сердечно-сосудистой системы. Под ред. Л.С. Лилли; пер. с англ. М.: Бином. Лаборатория знаний, 2016: 735 с.

[30] Lilly L.S. Pathophysiology of the cardiovascular system. Ed. by L.S. Lilly; translated from English. M.: Binom. Knowledge laboratory. 2016: 735 р. (In Russ.)

[31] Fadini G.P., Simoni F., Cappellari R., Previato L., Avogaro A. Pro-inflammatory monocyte-macrophage polarization imbalance in human hypercholesterolemia and atherosclerosis. Atherosclerosis. 2014; 237 (2): 805-808. DOI: 10.1016/j.atherosclerosis.2014.10.106.

[32] Fadini G.P., Simoni F., Cappellari R., Previato L., Avogaro A. Pro-inflammatory monocyte-macrophage polarization imbalance in human hypercholesterolemia and atherosclerosis. Atherosclerosis. 2014; 237 (2): 805–808. DOI: 10.1016/j.atherosclerosis.2014.10.106.

[33] Jaipersad A.S., Shantsila A., Lip G.Y.H., Shantsila E. Expression of monocyte subsets and angiogenic markers in relation to carotid plaque neovascularization in patients with pre-existing coronary artery disease and carotid stenosis. Ann. Med. 2014; 46 (7): 530-538. DOI: 10.3109/07853890.2014.931101.

[34] Jaipersad A.S., Shantsila A., Lip G.Y.H., Shantsila E. Expression of monocyte subsets and ­angiogenic markers in relation to carotid plaque neovascularization in patients with pre-existing coronary artery disease and carotid stenosis. Ann. Med. 2014; 46 (7): 530–538. DOI: 10.3109/07853890.2014.931101.

[35] Esper R.J. Hypertension arterial mechanics and other issues. Revista Argentina de Cardiologia. 2011; 79 (4): 13.

[36] Esper R.J. Hypertension arterial mechanics and ­other issues. Revista Argentina de Cardiologia. 2011; 79 (4): 13.

RIGHTS & PERMISSIONS

Azarova D.A., Chumakova S.P., Urazova O.I., Vins M.V., Shipulin V.M., Pryakhin A.S., Novitskiy V.V.